ZLAB Stock Analysis: Buy, Sell, or Hold?

ZLAB - Zai Lab Limited American Depositary Shares

PHARMACEUTICAL PREPARATIONS
$19.12
-0.03 (-0.16%) ▼
5d: +3.24%
30d: +11.49%
90d: -6.0%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026

Get Alerted When ZLAB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: ZLAB shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ZLAB is currently trading at $19.12, which is considered fair relative to its 30-day fair value range of $17.15 to $18.62.

Technical Outlook: Technically, ZLAB is showing sideways momentum. The price is approaching resistance at $19.61. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ZLAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.30 (+74.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $17.15 - $18.62
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 74.2% below Wall St target ($33.30)

Trading Range Analysis

30-Day Trading Range $17.15 - $18.62
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $17.23
Resistance Level $19.61
Current Trend Sideways
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -10.95
Wall Street Target $33.30 (+74.2%)
Revenue Growth (YoY) -6.5%
Profit Margin -39.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 9:37 PM ET
Data refreshes hourly during market hours. Next update: 10:37 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Rafael Amado SELL 2739 shares 2026-04-06
Yajing Chen SELL 853 shares 2026-04-06
Ying Du SELL 2653 shares 2026-04-06

Unlock Insider Activity

See real-time buying/selling by company executives for ZLAB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$549 59 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$106 64 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 54 HOLD
CLDX
Celldex Therapeutics Inc
STRONG BUY
15 analysts
$58 57 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 45 HOLD

More Analysis for ZLAB

ZLAB Technical Chart ZLAB Price Prediction ZLAB Earnings Date ZLAB Investment Advisor ZLAB Fair Price Analyzer ZLAB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals